Cambridge Investment Research Advisors, Inc. En V Veno Medical Corp Transaction History
Cambridge Investment Research Advisors, Inc.
- $32.9 Billion
- Q2 2025
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in En V Veno Medical Corp stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 10,001 shares of NVNO stock, worth $7,300. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,001Holding current value
$7,300% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding NVNO
# of Institutions
40Shares Held
5.48MCall Options Held
29KPut Options Held
0-
Perceptive Advisors LLC New York, NY1.28MShares$938,0250.23% of portfolio
-
Kingdon Capital Management, L.L.C. New York, NY859KShares$627,2600.54% of portfolio
-
Vanguard Group Inc Valley Forge, PA698KShares$509,7870.0% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT595KShares$434,1020.1% of portfolio
-
Act Capital Management, LLC Wayne, PA401KShares$292,8763.48% of portfolio
About enVVeno Medical Corp
- Ticker NVNO
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 9,469,850
- Market Cap $6.91M
- Description
- enVVeno Medical Corporation, a medical device company, focuses on the development of various bioprosthetic tissue-based solutions to enhance the standard of care in the treatment of venous diseases. The company's lead product is the VenoValve, a surgical implant being developed for the treatment of severe deep venous chronic venous insufficiency...